|

Lenvatinib Mesylate Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 4-[3-Chloro-4-(N''-cyclopropylureido)phenoxy]7-methoxyquinoline-6-carboxamide Mesylate, E7080, Lenvima, Multi-Kinase Inhibitor E7080

Pipeline

Phase 2: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Stage IIB Pancreatic Cancer AJCC v81
  • Stage II Pancreatic Cancer AJCC v81
  • Advanced Pancreatic Ductal Adenocarcinoma1
  • Stage IIA Pancreatic Cancer AJCC v81
  • Unresectable Pancreatic Ductal Adenocarcinoma1

Duarte, California1 trial

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

City of Hope Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.